UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 22, 2005
ULTRALIFE BATTERIES, INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
------- ----------
(Commission File Number) (I.R.S. Employer Identification No.)
2000 Technology Parkway, Newark, New York 14513
-------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(315) 332-7100
--------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
1
Item 7.01. Regulation FD Disclosure.
Ultralife Batteries, Inc. (the "Company") announced that it has been awarded a
five-year production contract by the U.S. Defense Department, which could reach
a maximum value of $15 million, to provide its BA-5347/U non-rechargeable
lithium-manganese dioxide batteries to the U.S. Military. The Company's press
release is attached as Exhibit 99.1 to this Form 8-K, and the information set
forth therein is furnished under item 7.01.
Item 9.01. Financial Statements, Pro Forma Financials and Exhibits.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release dated February 22, 2005.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: February 22, 2005. By: /s/ Peter F. Comerford
---------------------------------
Peter F. Comerford
Vice President of Administration
& General Counsel
2
INDEX TO EXHIBITS
(99) Additional Exhibits
99.1 Press Release dated February 22, 2005.
3
Exhibit 99.1
Ultralife Batteries, Inc. Awarded BA-5347 Military Battery Contract;
Five-Year Contract Valued at up to $15 Million
NEWARK, N.Y.--(BUSINESS WIRE)--Feb. 22, 2005--Ultralife Batteries,
Inc. (NASDAQ:ULBI) has been awarded a five-year production contract by
the U.S. Defense Department, which could reach a maximum value of $15
million, to provide its BA-5347/U non-rechargeable lithium-manganese
dioxide batteries to the U.S. Military. The contract value represents
60 percent of a small business set-aside award. The company expects to
complete the qualification process before the end of 2005 after which
it will begin production shipments.
John D. Kavazanjian, Ultralife's president and chief executive
officer, said, "Following our recent award of the Next Gen II, Phase
IV rectangular battery contract, this five-year contract solidifies
Ultralife's position as the leader in the manufacture and supply of
lithium-manganese dioxide batteries to the U.S. Military."
The BA-5347/U is an 11 ampere-hour, 6-volt battery used to power
the widely used AN/PAS-13 Thermal Weapon sight.
About Ultralife Batteries, Inc.
Ultralife is a global provider of power solutions for diverse
applications. The company develops, manufactures and markets a wide
range of non-rechargeable and rechargeable batteries, charging systems
and accessories for use in military, industrial and consumer portable
electronic products. Through its range of standard products and
engineered solutions, Ultralife is able to provide the next generation
of power systems. Industrial, retail and government customers include
General Dynamics, Philips Medical Systems, Energizer, Kidde Safety,
Lowe's, Radio Shack and the national defense agencies of the United
States and United Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research
facilities are in Newark, New York, near Rochester. Ultralife (UK)
Ltd., a second manufacturing facility, is located in Abingdon, U.K.
Both facilities are ISO-9001 certified. Detailed information about
Ultralife is available at www.ultralifebatteries.com.
This press release may contain forward-looking statements based on
current expectations that involve a number of risks and uncertainties.
The potential risks and uncertainties that could cause actual results
to differ materially include: worsening global economic conditions,
increased competitive environment and pricing pressures, disruptions
related to restructuring actions and delays. Further information on
these factors and other factors that could affect Ultralife's
financial results is included in Ultralife's Securities and Exchange
Commission (SEC) filings, including the latest Annual Report on Form
10-K.
Note to editors: Photos for the battery and application mentioned
in this release, and other Ultralife military batteries, are available
at: http://www.ultralifebatteries.com/milphoto.asp.
Ultralife(R) is a registered trademark of Ultralife Batteries,
Inc.
CONTACT: Company Contact:
Ultralife Batteries, Inc.
Peter Comerford, 315-332-7100
pcomerford@ulbi.com
or
Investor Relations Contact:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jburfening@lhai.com
or
Media Contact:
Lippert/Heilshorn & Associates, Inc.
Chenoa Taitt, 212-201-6635
ctaitt@lhai.com